284 related articles for article (PubMed ID: 15279066)
1. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
2. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
3. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.
Furukawa K; Thampoe IJ; Yamaguchi H; Lloyd KO
J Immunol; 1989 Feb; 142(3):848-54. PubMed ID: 2464027
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
6. Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells.
Thampoe IJ; Furukawa K; Vellvé E; Lloyd KO
Cancer Res; 1989 Nov; 49(22):6258-64. PubMed ID: 2804971
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
[TBL] [Abstract][Full Text] [Related]
8. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis.
Kawashima I; Ozawa H; Kotani M; Suzuki M; Kawano T; Gomibuchi M; Tai T
J Biochem; 1993 Aug; 114(2):186-93. PubMed ID: 8262898
[TBL] [Abstract][Full Text] [Related]
10. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
11. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
[TBL] [Abstract][Full Text] [Related]
13. A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.
Ye JN; Cheung NK
Int J Cancer; 1992 Jan; 50(2):197-201. PubMed ID: 1730513
[TBL] [Abstract][Full Text] [Related]
14. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
[TBL] [Abstract][Full Text] [Related]
15. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
Ozawa H; Kawashima I; Tai T
Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
[TBL] [Abstract][Full Text] [Related]
16. Production of monoclonal antibodies specific for ganglioside GD3.
Watarai S; Onuma M; Yasuda T
J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
[TBL] [Abstract][Full Text] [Related]
17. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736
[TBL] [Abstract][Full Text] [Related]
18. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.
Tai T; Kawashima I; Furukawa K; Lloyd KO
Arch Biochem Biophys; 1988 Jan; 260(1):51-5. PubMed ID: 2449128
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
